Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation: demonstration of a graft-versus-myelofibrosis effect

被引:48
作者
Cervantes, F [1 ]
Rovira, M [1 ]
Urbano-Ispizua, A [1 ]
Rozman, M [1 ]
Carreras, E [1 ]
Montserrat, E [1 ]
机构
[1] Univ Barcelona, Hosp Clin, Dept Hematol, Inst Hematol & Oncol,IDIBAPS, E-08036 Barcelona, Spain
关键词
idiopathic myelofibrosis; agnogenic myeloid metaplasia; allogeneic transplantation; donor lymphocyte infusion; graft-versus-host disease; graft-versus-disease effect;
D O I
10.1038/sj.bmt.1702568
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
A patient with idiopathic myelofibrosis (IM) in the osteosclerotic phase received an allogeneic stem cell transplant. Hemopoietic engraftment was rapid, and full donor chimerism was observed on day +70. However, a few months later, replacement of donor hemopoiesis by the patient's 20q- cell clone was observed, followed by reappearance of the blood IM features, marrow fibrosis and osteosclerosis, At 8 months from transplant donor lymphocytes were infused, which induced chronic GVHD, This resulted in normalization of the blood, with disappearance of the fibrosis and osteosclerosis, effects which persisted 20 months later. This case provides evidence for a graft-versus-disease effect in IM.
引用
收藏
页码:697 / 699
页数:3
相关论文
共 10 条
  • [1] Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines
    Barosi, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2954 - 2970
  • [2] MYELOFIBROSIS CLINICAL, HEMATOLOGIC AND PATHOLOGIC STUDY OF 110 PATIENTS
    BOURONCLE, BA
    DOAN, CA
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1962, 243 (06) : 697 - &
  • [3] Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups
    Cervantes, F
    Barosi, G
    Demory, JL
    Reilly, J
    Guarnone, R
    Dupriez, B
    Pereira, A
    Montserrat, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) : 684 - 690
  • [4] Dazzi F, 1999, Curr Opin Hematol, V6, P394, DOI 10.1097/00062752-199911000-00007
  • [5] DEMORY JL, 1988, BLOOD, V72, P855
  • [6] Guardiola P, 1999, BLOOD, V93, P2831
  • [7] JACOBSON RJ, 1978, BLOOD, V51, P189
  • [8] DONOR LEUKOCYTE TRANSFUSIONS FOR TREATMENT OF RECURRENT CHRONIC MYELOGENOUS LEUKEMIA IN MARROW TRANSPLANT PATIENTS
    KOLB, HJ
    MITTERMULLER, J
    CLEMM, C
    HOLLER, E
    LEDDEROSE, G
    BREHM, G
    HEIM, M
    WILMANNS, W
    [J]. BLOOD, 1990, 76 (12) : 2462 - 2465
  • [9] INDUCTION OF GRAFT-VERSUS-HOST DISEASE AS IMMUNOTHERAPY FOR RELAPSED CHRONIC MYELOID-LEUKEMIA
    PORTER, DL
    ROTH, MS
    MCGARIGLE, C
    FERRARA, JLM
    ANTIN, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (02) : 100 - 106
  • [10] Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
    Slavin, S
    Nagler, A
    Naparstek, E
    Kapelushnik, Y
    Aker, M
    Cividalli, G
    Varadi, G
    Kirschbaum, M
    Ackerstein, A
    Samuel, S
    Amar, A
    Brautbar, C
    Ben-Tal, O
    Eldor, A
    Or, R
    [J]. BLOOD, 1998, 91 (03) : 756 - 763